2025 North America Automatic Nucleic Acid Extraction Instrument Market Revenue Opportunities Report
Description
The 2025 North America Automatic Nucleic Acid Extraction Instrument Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Automatic Nucleic Acid Extraction Instrument Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the North American Automatic Nucleic Acid Extraction Instrument market are Thermo Fisher Scientific, Inc., QIAGEN NV, F. Hoffmann-La Roche AG, and PerkinElmer Inc. Thermo Fisher Scientific leads with broad offerings in automated nucleic acid extraction devices and recently developed automated systems for forensic labs, reflecting strong innovation and market presence. QIAGEN has expanded its liquid biopsy portfolio with advanced automated kits supporting large sample volumes, positioning itself as a key player in cancer research and biomarker discovery. F. Hoffmann-La Roche AG and PerkinElmer also maintain significant market shares, with the latter known for comprehensive laboratory technologies, including nucleic acid extraction instruments, supporting diverse industries.
These companies drive growth in North America’s market, which is the largest region globally, supported by expanding applications in molecular diagnostics, genomics, and personalized medicine. Automation and high-throughput capabilities from these firms respond to increasing demand in clinical and research labs. Market growth is accelerated by rising investments in R&D, strategic mergers, and new product launches enhancing workflow efficiency and nucleic acid isolation accuracy. Their strong regional presence and innovation pipelines position them dominantly in the evolving nucleic acid extraction landscape.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Automatic Nucleic Acid Extraction Instrument Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the North American Automatic Nucleic Acid Extraction Instrument market are Thermo Fisher Scientific, Inc., QIAGEN NV, F. Hoffmann-La Roche AG, and PerkinElmer Inc. Thermo Fisher Scientific leads with broad offerings in automated nucleic acid extraction devices and recently developed automated systems for forensic labs, reflecting strong innovation and market presence. QIAGEN has expanded its liquid biopsy portfolio with advanced automated kits supporting large sample volumes, positioning itself as a key player in cancer research and biomarker discovery. F. Hoffmann-La Roche AG and PerkinElmer also maintain significant market shares, with the latter known for comprehensive laboratory technologies, including nucleic acid extraction instruments, supporting diverse industries.
These companies drive growth in North America’s market, which is the largest region globally, supported by expanding applications in molecular diagnostics, genomics, and personalized medicine. Automation and high-throughput capabilities from these firms respond to increasing demand in clinical and research labs. Market growth is accelerated by rising investments in R&D, strategic mergers, and new product launches enhancing workflow efficiency and nucleic acid isolation accuracy. Their strong regional presence and innovation pipelines position them dominantly in the evolving nucleic acid extraction landscape.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
